Chronic Obstructive Pulmonary Disease Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for chronic obstructive pulmonary disease in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

    This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COP…

    Stage
    Phase 3
    Ages
    40 to 80
    Site
    Temple University Hospital - Main Campus- Site Number : 8400059, Philadelphia, Pennsylvania
    Locations
    221 in total
    Run by
    Sanofi

    See if you can join NCT07190209 on ClinicalTrials.gov

  2. Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

    The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard medical care. The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System in the treatment of COPD.

    Stage
    Not phased
    Ages
    40 to 80
    Site
    Temple University - Temple Lung Center, Philadelphia, Pennsylvania
    Locations
    10 in total
    Run by
    Nuvaira, Inc.

    See if you can join NCT07051707 on ClinicalTrials.gov

  3. Feasibility of Semaglutide in Advanced Lung Disease

    The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung disease. The main question[s] it aims to answer are: 1. Are patients with advanced lung disease able to tolerate semaglutide …

    Stage
    Phase 1
    Ages
    18 to 80
    Site
    University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT05746039 on ClinicalTrials.gov

  4. Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

    The COPD in LCS Registry will identify and characterize individuals who have functional or radiographic evidence of COPD and are receiving lung cancer screening. Clinical information will be obtained from study participants including symptom burden, lung cancer risk, spirometry, imaging characteris…

    Stage
    Not phased
    Ages
    50 to 80
    Site
    Thomas Jefferson University, Philadelphia, Pennsylvania
    Run by
    Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

    See if you can join NCT06974981 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.